813 related articles for article (PubMed ID: 16446333)
21. [Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years].
Dörffel W; Albrecht M; Lüders H; Marciniak H; Parwaresch R; Schwarze EW; Trauzeddel R; Havers W; Henze G; Janka-Schaub G; Mann G; Niemeyer C; Pötter R; Schellong G; Selle B; Treuner J; Rühl U
Klin Padiatr; 1998; 210(4):212-9. PubMed ID: 9743955
[TBL] [Abstract][Full Text] [Related]
22. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol].
Moryl-Bujakowska A; Balwierz W; Sztefko K
Przegl Lek; 2004; 61 Suppl 2():81-4. PubMed ID: 15686053
[TBL] [Abstract][Full Text] [Related]
23. Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern era.
Zapatero A; López MA; Cerezo L; De Vidales CM; MarIn A; Pérez-Torrubia A
Hematology; 2002 Feb; 7(1):43-50. PubMed ID: 12171776
[TBL] [Abstract][Full Text] [Related]
24. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
Tebbi CK; Mendenhall N; London WB; Williams JL; de Alarcon PA; Chauvenet AR;
Pediatr Blood Cancer; 2006 Feb; 46(2):198-202. PubMed ID: 16136581
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
26. Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.
Chen RC; Chin MS; Ng AK; Feng Y; Neuberg D; Silver B; Pinkus GS; Stevenson MA; Mauch PM
J Clin Oncol; 2010 Jan; 28(1):136-41. PubMed ID: 19933914
[TBL] [Abstract][Full Text] [Related]
27. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
28. Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: local disease control with combined-modality therapy.
Krasin MJ; Rai SN; Kun LE; Merchant TE; Metzger ML; Kaste SC; Howard SC; Hudson MM
J Clin Oncol; 2005 Nov; 23(33):8406-13. PubMed ID: 16293871
[TBL] [Abstract][Full Text] [Related]
29. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
30. [Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?].
Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML
Vopr Onkol; 2007; 53(4):453-5. PubMed ID: 17969410
[TBL] [Abstract][Full Text] [Related]
31. [Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
Ben Hassouna J; Slimène M; Boussen H; Bouzaiene H; Khomsi F; Chargui R; Kochbati L; Mtaallah MH; Gamoudi A; Benna F; Hechiche M; Rahal K
Gynecol Obstet Fertil; 2007 Jun; 35(6):536-40. PubMed ID: 17543568
[TBL] [Abstract][Full Text] [Related]
32. [Can children with Hodgkin's disease be treated with chemotherapy only?].
Balwierz W; Klekawka T; Moryl-Bujakowska A; Matysiak M; Sopyło B; Wachowiak J; Kaczmarek-Kanold M; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Mitura-Lesiuk M; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Krawczuk-Rybak M; Muszyńska-Rosłan K; Młynarski W; Stolarska M; Sobol G; Wieczorek M; Karolczyk G; Urbanek-Dadela A
Przegl Lek; 2010; 67(6):375-81. PubMed ID: 21344765
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin's lymphoma in adolescents.
Foltz LM; Song KW; Connors JM
J Clin Oncol; 2006 Jun; 24(16):2520-6. PubMed ID: 16735704
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.
Wirth A; Yuen K; Barton M; Roos D; Gogna K; Pratt G; Macleod C; Bydder S; Morgan G; Christie D
Cancer; 2005 Sep; 104(6):1221-9. PubMed ID: 16094666
[TBL] [Abstract][Full Text] [Related]
35. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Donaldson SS; Link MP; Weinstein HJ; Rai SN; Brain S; Billett AL; Hurwitz CA; Krasin M; Kun LE; Marcus KC; Tarbell NJ; Young JA; Hudson MM
J Clin Oncol; 2007 Jan; 25(3):332-7. PubMed ID: 17235049
[TBL] [Abstract][Full Text] [Related]
36. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
37. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
38. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of efficacy of chemoradiotherapy for Hodgkin's disease].
Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Malinin AP; Golovanov SG
Vopr Onkol; 2004; 50(6):652-7. PubMed ID: 15755057
[TBL] [Abstract][Full Text] [Related]
40. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
